APO Research, Inc.

APO RESEARCH · REPORT

Alpha-Amylase

Selected research

Market Outlook & Growth Opportunities

Global Alpha-Amylase Market Outlook and Growth Opportunities 2026

Market perspective

The global Alpha-Amylase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Alpha-Amylase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alpha-Amylase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha-Amylase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Alpha-Amylase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Alpha-Amylase market include Novozymes, Calzyme, Biogreen Technochem, Sigma-Aldrich, Enmex and Biolaxi Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alpha-Amylase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alpha-Amylase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alpha-Amylase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alpha-Amylase market size, projected growth trends, production technologies, key applications, and end-use industries.

Alpha-Amylase Segment by Company

Novozymes

Calzyme

Biogreen Technochem

Sigma-Aldrich

Enmex

Biolaxi Corporation

Alpha-Amylase Segment by Type

Plants

Bacteria

Fungi

Alpha-Amylase Segment by Application

Fruit Ripening

Medical Diagnostics

Flour Improvers

Malt Production

Alpha-Amylase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Alpha-Amylase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Alpha-Amylase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alpha-Amylase significant trends, drivers, influence factors in global and regions.

6. To analyze Alpha-Amylase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha-Amylase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha-Amylase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha-Amylase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alpha-Amylase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alpha-Amylase industry.

Chapter 3: Detailed analysis of Alpha-Amylase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Alpha-Amylase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Alpha-Amylase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alpha-Amylase Industry Trends Table 2. Alpha-Amylase Industry Drivers Table 3. Alpha-Amylase Industry Opportunities and Challenges Table 4. Alpha-Amylase Industry Restraints Table 5. Global Alpha-Amylase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alpha-Amylase Revenue Share by Company (2021-2026) Table 7. Global Alpha-Amylase Sales Volume by Company (kt) & (2021-2026) Table 8. Global Alpha-Amylase Sales Volume Share by Company (2021-2026) Table 9. Global Alpha-Amylase Average Price (USD/t) of Company (2021-2026) Table 10. Global Alpha-Amylase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Alpha-Amylase Key Company Manufacturing Base & Headquarters Table 12. Global Alpha-Amylase Company, Product Type & Application Table 13. Global Alpha-Amylase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Alpha-Amylase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plants Table 18. Significant Companies of Bacteria Table 19. Significant Companies of Fungi Table 20. Global Alpha-Amylase Sales Volume by Type 2021 VS 2025 VS 2032 (kt) Table 21. Global Alpha-Amylase Sales Volume by Type (2021-2026) & (kt) Table 22. Global Alpha-Amylase Sales Volume by Type (2027-2032) & (kt) Table 23. Global Alpha-Amylase Sales Volume Share by Type (2021-2026) Table 24. Global Alpha-Amylase Sales Volume Share by Type (2027-2032) Table 25. Global Alpha-Amylase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Alpha-Amylase Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Alpha-Amylase Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Alpha-Amylase Sales Value Share by Type (2021-2026) Table 29. Global Alpha-Amylase Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Fruit Ripening Table 31. Significant Companies of Medical Diagnostics Table 32. Significant Companies of Flour Improvers Table 33. Significant Companies of Malt Production Table 34. Global Alpha-Amylase Sales Volume by Application 2021 VS 2025 VS 2032 (kt) Table 35. Global Alpha-Amylase Sales Volume by Application (2021-2026) & (kt) Table 36. Global Alpha-Amylase Sales Volume by Application (2027-2032) & (kt) Table 37. Global Alpha-Amylase Sales Volume Share by Application (2021-2026) Table 38. Global Alpha-Amylase Sales Volume Share by Application (2027-2032) Table 39. Global Alpha-Amylase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Alpha-Amylase Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Alpha-Amylase Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Alpha-Amylase Sales Value Share by Application (2021-2026) Table 43. Global Alpha-Amylase Sales Value Share by Application (2027-2032) Table 44. Global Alpha-Amylase Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 45. Global Alpha-Amylase Sales by Region (2021-2026) & (kt) Table 46. Global Alpha-Amylase Sales Market Share by Region (2021-2026) Table 47. Global Alpha-Amylase Sales by Region (2027-2032) & (kt) Table 48. Global Alpha-Amylase Sales Market Share by Region (2027-2032) Table 49. Global Alpha-Amylase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Alpha-Amylase Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Alpha-Amylase Sales Value Share by Region (2021-2026) Table 52. Global Alpha-Amylase Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Alpha-Amylase Sales Value Share by Region (2027-2032) Table 54. Global Alpha-Amylase Market Average Price (USD/t) by Region (2021-2026) Table 55. Global Alpha-Amylase Market Average Price (USD/t) by Region (2027-2032) Table 56. Global Alpha-Amylase Sales by Country: 2021 VS 2025 VS 2032 (kt) Table 57. Global Alpha-Amylase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Alpha-Amylase Sales by Country (2021-2026) & (kt) Table 59. Global Alpha-Amylase Sales Market Share by Country (2021-2026) Table 60. Global Alpha-Amylase Sales by Country (2027-2032) & (kt) Table 61. Global Alpha-Amylase Sales Market Share by Country (2027-2032) Table 62. Global Alpha-Amylase Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Alpha-Amylase Sales Value Market Share by Country (2021-2026) Table 64. Global Alpha-Amylase Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Alpha-Amylase Sales Value Market Share by Country (2027-2032) Table 66. Novozymes Company Information Table 67. Novozymes Business Overview Table 68. Novozymes Alpha-Amylase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. Novozymes Alpha-Amylase Product Portfolio Table 70. Novozymes Recent Development Table 71. Calzyme Company Information Table 72. Calzyme Business Overview Table 73. Calzyme Alpha-Amylase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Calzyme Alpha-Amylase Product Portfolio Table 75. Calzyme Recent Development Table 76. Biogreen Technochem Company Information Table 77. Biogreen Technochem Business Overview Table 78. Biogreen Technochem Alpha-Amylase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Biogreen Technochem Alpha-Amylase Product Portfolio Table 80. Biogreen Technochem Recent Development Table 81. Sigma-Aldrich Company Information Table 82. Sigma-Aldrich Business Overview Table 83. Sigma-Aldrich Alpha-Amylase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Sigma-Aldrich Alpha-Amylase Product Portfolio Table 85. Sigma-Aldrich Recent Development Table 86. Enmex Company Information Table 87. Enmex Business Overview Table 88. Enmex Alpha-Amylase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Enmex Alpha-Amylase Product Portfolio Table 90. Enmex Recent Development Table 91. Biolaxi Corporation Company Information Table 92. Biolaxi Corporation Business Overview Table 93. Biolaxi Corporation Alpha-Amylase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Biolaxi Corporation Alpha-Amylase Product Portfolio Table 95. Biolaxi Corporation Recent Development Table 96. Key Raw Materials Table 97. Raw Materials Key Suppliers Table 98. Alpha-Amylase Distributors List Table 99. Alpha-Amylase Customers List Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Alpha-Amylase Product Image Figure 2. Global Alpha-Amylase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha-Amylase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Alpha-Amylase Sales (2021-2032) & (kt) Figure 5. Global Alpha-Amylase Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Alpha-Amylase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plants Image Figure 10. Bacteria Image Figure 11. Fungi Image Figure 12. Global Alpha-Amylase Sales Volume by Type (2021 VS 2025 VS 2032) & (kt) Figure 13. Global Alpha-Amylase Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Alpha-Amylase Sales Volume Share by Type (2021-2032) Figure 15. Global Alpha-Amylase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Alpha-Amylase Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Alpha-Amylase Sales Value Share by Type (2021-2032) Figure 18. Fruit Ripening Image Figure 19. Medical Diagnostics Image Figure 20. Flour Improvers Image Figure 21. Malt Production Image Figure 22. Global Alpha-Amylase Sales Volume by Application (2021 VS 2025 VS 2032) & (kt) Figure 23. Global Alpha-Amylase Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Alpha-Amylase Sales Volume Share by Application (2021-2032) Figure 25. Global Alpha-Amylase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Alpha-Amylase Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Alpha-Amylase Sales Value Share by Application (2021-2032) Figure 28. Global Alpha-Amylase Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 29. Global Alpha-Amylase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Alpha-Amylase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Alpha-Amylase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Alpha-Amylase Sales Value (2021-2032) & (US$ Million) Figure 33. North America Alpha-Amylase Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Alpha-Amylase Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Alpha-Amylase Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Alpha-Amylase Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Alpha-Amylase Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Alpha-Amylase Sales Value (2021-2032) & (US$ Million) Figure 39. South America Alpha-Amylase Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Alpha-Amylase Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Alpha-Amylase Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Alpha-Amylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Alpha-Amylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Alpha-Amylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Alpha-Amylase Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Alpha-Amylase Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Plants
  • Bacteria
  • Fungi
Applications
  • Fruit Ripening
  • Medical Diagnostics
  • Flour Improvers
  • Malt Production
Companies covered
  • Novozymes
  • Calzyme
  • Biogreen Technochem
  • Sigma-Aldrich
  • Enmex
  • Biolaxi Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alpha-Amylase Sales Value (2021-2032)
  4. 1.2.2 Global Alpha-Amylase Sales Volume (2021-2032)
  5. 1.2.3 Global Alpha-Amylase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Alpha-Amylase Market Dynamics
  1. 2.1 Alpha-Amylase Industry Trends
  2. 2.2 Alpha-Amylase Industry Drivers
  3. 2.3 Alpha-Amylase Industry Opportunities and Challenges
  4. 2.4 Alpha-Amylase Industry Restraints
3 Alpha-Amylase Market by Company
  1. 3.1 Global Alpha-Amylase Company Revenue Ranking in 2025
  2. 3.2 Global Alpha-Amylase Revenue by Company (2021-2026)
  3. 3.3 Global Alpha-Amylase Sales Volume by Company (2021-2026)
  4. 3.4 Global Alpha-Amylase Average Price by Company (2021-2026)
  5. 3.5 Global Alpha-Amylase Company Ranking (2024-2026)
  6. 3.6 Global Alpha-Amylase Company Manufacturing Base and Headquarters
  7. 3.7 Global Alpha-Amylase Company Product Type and Application
  8. 3.8 Global Alpha-Amylase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Alpha-Amylase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Alpha-Amylase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Alpha-Amylase Market by Type
  1. 4.1 Alpha-Amylase Type Introduction
  2. 4.1.1 Plants
  3. 4.1.2 Bacteria
  4. 4.1.3 Fungi
  5. 4.2 Global Alpha-Amylase Sales Volume by Type
  6. 4.2.1 Global Alpha-Amylase Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Alpha-Amylase Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Alpha-Amylase Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Alpha-Amylase Sales Value by Type
  10. 4.3.1 Global Alpha-Amylase Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Alpha-Amylase Sales Value by Type (2021-2032)
  12. 4.3.3 Global Alpha-Amylase Sales Value Share by Type (2021-2032)
5 Alpha-Amylase Market by Application
  1. 5.1 Alpha-Amylase Application Introduction
  2. 5.1.1 Fruit Ripening
  3. 5.1.2 Medical Diagnostics
  4. 5.1.3 Flour Improvers
  5. 5.1.4 Malt Production
  6. 5.2 Global Alpha-Amylase Sales Volume by Application
  7. 5.2.1 Global Alpha-Amylase Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Alpha-Amylase Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Alpha-Amylase Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Alpha-Amylase Sales Value by Application
  11. 5.3.1 Global Alpha-Amylase Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Alpha-Amylase Sales Value by Application (2021-2032)
  13. 5.3.3 Global Alpha-Amylase Sales Value Share by Application (2021-2032)
6 Alpha-Amylase Regional Sales and Value Analysis
  1. 6.1 Global Alpha-Amylase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alpha-Amylase Sales by Region (2021-2032)
  3. 6.2.1 Global Alpha-Amylase Sales by Region: 2021-2026
  4. 6.2.2 Global Alpha-Amylase Sales by Region (2027-2032)
  5. 6.3 Global Alpha-Amylase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Alpha-Amylase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Alpha-Amylase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Alpha-Amylase Sales Value by Region (2027-2032)
  9. 6.5 Global Alpha-Amylase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Alpha-Amylase Sales Value (2021-2032)
  12. 6.6.2 North America Alpha-Amylase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Alpha-Amylase Sales Value (2021-2032)
  15. 6.7.2 Europe Alpha-Amylase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Alpha-Amylase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Alpha-Amylase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Alpha-Amylase Sales Value (2021-2032)
  21. 6.9.2 South America Alpha-Amylase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Alpha-Amylase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Alpha-Amylase Sales Value Share by Country, 2025 VS 2032
7 Alpha-Amylase Country-level Sales and Value Analysis
  1. 7.1 Global Alpha-Amylase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alpha-Amylase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Alpha-Amylase Sales by Country (2021-2032)
  4. 7.3.1 Global Alpha-Amylase Sales by Country (2021-2026)
  5. 7.3.2 Global Alpha-Amylase Sales by Country (2027-2032)
  6. 7.4 Global Alpha-Amylase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Alpha-Amylase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Alpha-Amylase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Alpha-Amylase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Alpha-Amylase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Alpha-Amylase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Alpha-Amylase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Alpha-Amylase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Alpha-Amylase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Alpha-Amylase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Alpha-Amylase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Alpha-Amylase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Alpha-Amylase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Alpha-Amylase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Alpha-Amylase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Alpha-Amylase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Alpha-Amylase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Alpha-Amylase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Alpha-Amylase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Alpha-Amylase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Alpha-Amylase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Alpha-Amylase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Alpha-Amylase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Alpha-Amylase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Alpha-Amylase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Alpha-Amylase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Alpha-Amylase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Alpha-Amylase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Alpha-Amylase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Alpha-Amylase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Alpha-Amylase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novozymes
  2. 8.1.1 Novozymes Company Information
  3. 8.1.2 Novozymes Business Overview
  4. 8.1.3 Novozymes Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novozymes Alpha-Amylase Product Portfolio
  6. 8.1.5 Novozymes Recent Developments
  7. 8.2 Calzyme
  8. 8.2.1 Calzyme Company Information
  9. 8.2.2 Calzyme Business Overview
  10. 8.2.3 Calzyme Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Calzyme Alpha-Amylase Product Portfolio
  12. 8.2.5 Calzyme Recent Developments
  13. 8.3 Biogreen Technochem
  14. 8.3.1 Biogreen Technochem Company Information
  15. 8.3.2 Biogreen Technochem Business Overview
  16. 8.3.3 Biogreen Technochem Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Biogreen Technochem Alpha-Amylase Product Portfolio
  18. 8.3.5 Biogreen Technochem Recent Developments
  19. 8.4 Sigma-Aldrich
  20. 8.4.1 Sigma-Aldrich Company Information
  21. 8.4.2 Sigma-Aldrich Business Overview
  22. 8.4.3 Sigma-Aldrich Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sigma-Aldrich Alpha-Amylase Product Portfolio
  24. 8.4.5 Sigma-Aldrich Recent Developments
  25. 8.5 Enmex
  26. 8.5.1 Enmex Company Information
  27. 8.5.2 Enmex Business Overview
  28. 8.5.3 Enmex Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Enmex Alpha-Amylase Product Portfolio
  30. 8.5.5 Enmex Recent Developments
  31. 8.6 Biolaxi Corporation
  32. 8.6.1 Biolaxi Corporation Company Information
  33. 8.6.2 Biolaxi Corporation Business Overview
  34. 8.6.3 Biolaxi Corporation Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Biolaxi Corporation Alpha-Amylase Product Portfolio
  36. 8.6.5 Biolaxi Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alpha-Amylase Value Chain Analysis
  2. 9.1.1 Alpha-Amylase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alpha-Amylase Sales Mode & Process
  6. 9.2 Alpha-Amylase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alpha-Amylase Distributors
  9. 9.2.3 Alpha-Amylase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.